ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Donor-Derived Cell-Free DNA Is Stable in Non-Rejecting Heart Transplant Recipients in the CARGO II Multicenter Trial

    D. Hiller,1 M. Grskovic,1 J. Beausang,1 R. Sit,1 B. Christie,1 J. Elechko,1 R. Woodward,1 J. Yee,1 H. Eisen.2

    1CareDx, Inc, Brisbane, CA; 2Drexel University, University of Philadelphia, Philadelphia, PA.

    Purpose: An elevated fraction of donor-derived cell-free DNA (dd-cfDNA) detected in the venous blood of recipients has been shown to be correlated to rejection of…
  • 2015 American Transplant Congress

    Molecular Correlates of Endothelial mTOR Activation in Heart Transplants Recipients

    M. Racape, A. Loupy, J. Reeve, J. Venner, R. Guillemain, L. Hidalgo, C. Lefaucheur, X. Jouven, P. Bruneval, P. Halloran, J. Duong.

    Paris Transplant Group & ATAGC, Paris - Edmonton, France.

    BackgroundThe detection of phosphorylated effectors of the mTOR pathway in endothelial cells has been associated with in allograft rejection in animal models. The aim of…
  • 2015 American Transplant Congress

    Outcome of Bortezomib/Plasmapheresis for the Sensitized Patient Awaiting Heart Transplant

    J. Patel, N. Reinsmoen, M. Kittleson, D. Dilibero, F. Liou, D. Chang, M. Hamilton, L. Czer, F. Esmailian, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles, CA.

    Purpose: Allosensitization of patients (pts) awaiting heart transplantation is a significant challenge as it prolongs the time to transplant, increases wait-list mortality and increases risk…
  • 2015 American Transplant Congress

    The Use of Eculizumab to Treat the Highly Sensitized Patient Awaiting Heart Transplant

    J. Patel, D. Dilibero, M. Kittleson, S. Sana, F. Liou, D. Chang, A. Hage, L. Czer, A. Trento, N. Reinsmoen, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles, CA.

    Purpose: Highly sensitized patients (pts) awaiting heart transplantation remain a significant challenge due to prolonged often prohibitive wait times for suitable organs and increased rejection…
  • 2015 American Transplant Congress

    Epidemiology and Outcomes of Non Tuberculous Mycobacterial (NTM) Infections in Solid Organ Transplant (SOT) Recipients

    I. George, C. Santos, M. Olsen, T. Bailey.

    Infectious Diseases, Washington University School of Medicine, St. Louis, MO.

    Background: NTM are uncommon causes of infection in SOT recipients but may cause significant morbidity and mortality.Methods: A retrospective cohort of all patients who underwent…
  • 2015 American Transplant Congress

    Deep Surgical Site Infections (dSSI) After Liver Transplantation (LTx): Emergence of Multiple-Drug Resistant (MDR) Pathogens

    J. Viehman,1 L. Clarke,1 R. Shields,2 C. Clancy,2,3 M. Nguyen.1,2

    1University of Pittsburgh Medical Center, Pittsburgh, PA; 2University of Pittsburgh, Pittsburgh, PA; 3VA Pittsburgh Health System, Pittsburgh, PA.

    Purpose: We described the epidemiology, microbiology and outcomes of dSSI after LTx.Methods: We performed a single center retrospective study of 332 consecutive patients undergoing LTX…
  • 2015 American Transplant Congress

    Post-Kidney Transplant Infections in Desensitized Patients Receiving Thymoglobulin or Daclizumab Induction: Results of a Randomized Clinical Trial

    B. Orandi,1 J. Locke,2 E. Kraus,3 B. Lonze,1 N. Desai,1 N. Dagher,1 N. Alachkar,3 C. Simpkins,4 F. Naqvi,3 D. Segev,1 R. Montgomery,1 R. Avery.3

    1Department of Surgery, Johns Hopkins University, Baltimore; 2Department of Surgery, University of Alabama--Birmingham, Birmingham; 3Department of Medicine, Johns Hopkins University, Baltimore; 4Department of Surgery, Dartmouth, Lebanon.

    Live donor kidney transplant recipients requiring desensitization for donor-specific antibody, who were enrolled in a single-center randomized trial of thymoglobulin vs. daclizumab induction, were evaluated…
  • 2015 American Transplant Congress

    Epidemiology of Pneumonia in a Cohort of 5,000+ Abdominal Solid Organ Transplant Recipients

    A. Masica, S. Delcroix-Lopes, M. Kouznetsova, C. Spak.

    Baylor Scott & White Health, Dallas, TX.

    Study purposeWe evaluated the epidemiology of pneumonia (PNE) in a longitudinal cohort of patients with abdominal (kidney, liver, and/or pancreas) solid organ transplants (SOT).MethodsRetrospective study…
  • 2015 American Transplant Congress

    Efficacy of Low Dose Chemoprophylaxis for Coccidioidomycosis Infection in Liver Transplantation Recipients

    R. El Ramahi,2 S. Habib,1 S. Rosen,3 S. Farran,3 C. Walker,3 J. Shubeilat,4 S. Yost,5 O. McCotter,6 M. Cassal,6 A. Rana,7 T. Boyer,1 T. Zangeneh.2

    1Liver Research Institute, Divisions of Gastroenterology, Hepatology and Transplantation, Department of Medicine, University of Arizona, Tucson, AZ; 2Division of Infectious Disease, Department of Medicine, University of Arizona, Tucson, AZ; 3Internal Medicine Residency Program, Department of Medicine, University of Arizona, Tucson, AZ; 4Division of Infectious Disease, Department of Medicine, University of Massachusetts, Worcester, MA; 5Division of Transplantation, School of Pharmacy, University of Arizona, Tucson, AZ; 6Office of Border Health, Arizona Department of Health Services, Tucson, AZ; 7Division of Transplantation, Department of Surgery, University of Arizona, Tucson, AZ.

    Introduction:Coccidioidomycosis(CM) infection rate of 6.9% has been reported in solid organ transplantation recipients living in endemic Southwestern U.S.Aim:Assess the risk of CM infection in liver…
  • 2015 American Transplant Congress

    Outcomes Associated With Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) in Solid Organ Transplant (SOT) Recipients

    T. Bias,1 A. Sharma,2 G. Malat,3 D. Lee,2 A. Doyle.2

    1Dept of Pharmacy, Hahnemann University Hospital, Philadelphia; 2Dept of Medicine, Drexel University, College of Medicine, Philadelphia; 3Dept of Surgery, Drexel University, College of Medicine, Philadelphia, PA.

    Background: Infection with CRKP is emerging as an important challenge among SOT recipients. Our study aims to describe the epidemiology and clinical outcomes associated with…
  • « Previous Page
  • 1
  • …
  • 1350
  • 1351
  • 1352
  • 1353
  • 1354
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences